Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Rotation vs Dose Escalation in Cancer Pain
NCT02084355Phase 3Unknown
- Sponsor
- Gyeongsang National University Hospital
- Start
- Apr 2014
- Primary completion
- Dec 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone, hydromorphone, fentanyl (transdermal patch + oral transmucosal lozenge) in cancer pain, sponsored by Gyeongsang National University Hospital. Status: unknown.
02
Drugs
oxycodonehydromorphonefentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT02084355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084355.